02/12/2025
8:28 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025
7:26 AM | Cytokinetics (Issuer)
Landry Robert E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
7:18 AM | Cytokinetics (Issuer)
Landry Robert E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/11/2025
6:30 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
3:31 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:25 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
10:29 AM | Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
3:17 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
3:22 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:23 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:25 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CYTK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cytokinetics and its competitors with MarketBeat's FREE daily newsletter. |
01/06/2025
3:25 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:27 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:23 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:38 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:13 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
9:17 AM | Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:42 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:30 PM | Cytokinetics (Issuer)
Lee Sung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:32 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:22 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:28 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:46 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:01 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
6:05 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:38 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:10 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
5:02 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:04 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/04/2024
4:45 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
10:17 AM | Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:45 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
3:49 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:12 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:04 PM | BlackRock, Inc. (Filed by)
Cytokinetics (Subject)
| Form SC 13G/A | |
10/16/2024
5:45 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:32 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:08 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
4:24 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad) Would you like to know the historic win rate of every trade you take before you place it?
Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << |
10/03/2024
4:25 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:26 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:27 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:28 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:48 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
5:56 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:15 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:29 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
4:06 PM | Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:09 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:14 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:00 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:07 PM | Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
| Form 3/A | |
08/12/2024
4:31 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:32 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:21 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
7:06 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:14 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:36 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:39 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2024
3:17 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:47 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:21 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:11 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:24 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
5:15 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:06 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2024
4:06 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:03 PM | Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
7:00 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:02 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:04 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:05 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:07 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:12 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:26 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
7:04 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:39 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:13 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:17 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:22 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:24 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:16 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:08 PM | Bhanji Muna (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
4:13 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
4:23 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
9:02 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:30 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
06/03/2024
3:36 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:33 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:15 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:59 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:00 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:01 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:03 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:04 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:05 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
